A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects
Public ClinicalTrials.gov record NCT05215418. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind Study to Compare the Effects of VI-0521,Phentermine, and Placebo on Ambulatory Blood Pressure in Overweight or Obese Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is being conducted to evaluate the effect of VI-0521 (Qsymia®) on blood pressure as measured by 24-hour ambulatory blood pressure monitoring, compared to both placebo and an active control (phentermine 30 mg).
Study identification
- NCT ID
- NCT05215418
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 565 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 24, 2022
- Primary completion
- Apr 10, 2023
- Completion
- Apr 16, 2023
- Last update posted
- Jul 16, 2024
2022 – 2023
United States locations
- U.S. sites
- 28
- U.S. states
- 17
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site | Anniston | Alabama | 36207 | — |
| Clinical Site | Mobile | Alabama | 36608 | — |
| Clinical Site | Lincoln | California | 95648 | — |
| Clinical Site | Long Beach | California | 90806 | — |
| Clinical Site | Sacramento | California | 95821 | — |
| Clinical Site | Spring Valley | California | 91978 | — |
| Clinical Site | Upland | California | 91786 | — |
| Clinical Site | Washington D.C. | District of Columbia | 20011 | — |
| Clinical Site | Coral Gables | Florida | 33134 | — |
| Clinical Site | Miami | Florida | 33155 | — |
| Clinical Site | Port Orange | Florida | 23227 | — |
| Clinical Site | Brownsburg | Indiana | 46112 | — |
| Clinical Site | Evansville | Indiana | 47714 | — |
| Clinical Site | Wichita | Kansas | 67207 | — |
| Clinical Site | Lexington | Kentucky | 40509 | — |
| Clinical Site | Louisville | Kentucky | 40213 | — |
| Clinical Site | Baton Rouge | Louisiana | 70808 | — |
| Clinical Site | Kansas City | Missouri | 64114 | — |
| Clinical Site | Butte | Montana | 59701 | — |
| Clinical Site | Cary | North Carolina | 27518 | — |
| Clinical Site | Eugene | Oregon | 97404 | — |
| Clinical Site | Columbia | South Carolina | 29223 | — |
| Clinical Site | Knoxville | Tennessee | 37920 | — |
| Clinical Site | Friendswood | Texas | 77546 | — |
| Clinical Site | North Richland Hills | Texas | 76180 | — |
| Clinical Site | San Antonio | Texas | 78215 | — |
| Clinical site | Salt Lake City | Utah | 84124 | — |
| Clinical Site | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05215418, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 16, 2024 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05215418 live on ClinicalTrials.gov.